Administrative Memos

200005

FROM: Theodore O. Will, Chief Executive Officer
DATE: Oct 04, 2000
SUBJECT: Stroke Prevention in Stroke/Transient Ischemic Attack
IPRO CONTACTS:

Veronica Pryor, B.S., Assistant Director, Project Data Collection, ext. 631, Monte Malach, M.D.,F.A.C.C., M.A.C.P.,Medical Director/Clinical Coordinator,ext. 634, Marguerite Shaffer, C.P.H.Q., Director, Downstate Improvement Strategies, ext. 634 and Charles Stimler, M.D., M.P.H., Clinical Coordinator, ext. 634

Enclosed please find a statewide report on "Stroke Prevention in Stroke/Transient Ischemic Attack (TIA)". The purpose of this quality improvement project is to increase utilization of antithrombotic agents in eligible patients with previous stroke or transient ischemic attack with no contraindications.

IPRO has been working with physicians, providers and other health care personnel since 1994 to improve the use of anticoagulation therapy for eligible patients with atrial fibrillation. Although there has been improvement over the years, there still remains a significant number of patients who are not discharged on warfarin and have no documented contraindications.

The top one hundred high volume providers with a principal diagnosis of stroke or transient ischemic attack patients and their affiliated institutions which use the same Medicare provider number were identified and each will receive a hospital specific report on its individual baseline findings.